Flagship Pioneering as of Sept. 30, 2021
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 13 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 70.9 | $6.8B | 18M | 384.86 | |
| Sana Biotechnology (SANA) | 8.1 | $771M | 34M | 22.52 | |
| Rubius Therapeutics | 7.2 | $689M | 39M | 17.88 | |
| Omega Therapeutics (OMGAQ) | 5.1 | $488M | 26M | 18.85 | |
| Foghorn Therapeutics (FHTX) | 1.8 | $177M | 13M | 13.93 | |
| Evelo Biosciences | 1.7 | $162M | 23M | 7.04 | |
| Denali Therapeutics (DNLI) | 1.4 | $138M | 2.7M | 50.45 | |
| Kaleido Biosciences Ord (KLDO) | 1.1 | $107M | 20M | 5.46 | |
| Seres Therapeutics | 1.0 | $100M | 14M | 6.96 | |
| Sigilon Therapeutics | 0.6 | $59M | 10M | 5.65 | |
| Codiak Biosciences | 0.4 | $43M | 2.6M | 16.33 | |
| Axcella Health Inc equity | 0.4 | $37M | 13M | 2.98 | |
| Syros Pharmaceuticals | 0.1 | $13M | 2.9M | 4.47 |
